Pacific Biosciences Enters Agreement for Up to $100 Million At-the-Market Share Offering

• Pacific Biosciences signed a sales agreement November 10, 2026, for up to $100 million in common stock through an at-the-market offering.
• Allen & Company will act as sales agent, earning up to 3% of aggregate gross proceeds from shares sold through it.
• The company has no obligation to sell shares and may suspend the offering at any time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Biosciences of California Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-125166), on November 10, 2026, and is solely responsible for the information contained therein.